x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BioTech Nation ... with Dr. Moira Gunn

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for

science life sciences

All Episodes

25:34

23-04 Sir Rory Collins, Oxford Professor and...

BioTech Nation ... with Dr. Moira Gunn ·

2023/01/25

Sir Rory Collins is a Professor of Medicine and Epidemiology at the University of Oxford and the Principal Investigator of the UK Biobank. With data from half a million people, it has served 30,000 scientists around the world, giving special support to young researchers and scientists in emergent countries.

en

16:14

23-03 Dr. Rob Ross, CEO, Surface Oncology

BioTech Nation ... with Dr. Moira Gunn ·

2023/01/15

Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.

en

25:57

Antidepressants Should Have Diagnostics???

BioTech Nation ... with Dr. Moira Gunn ·

2023/01/10

Major Depressive Disorder. Serious Depression. PTSD. Alto Neuroscience CEO, Dr. Amit Etkin talks about developing new and innovative drugs tied directly to each patient’s underlying biology. For every drug, there is a test...

en

30:24

23-01 Gene Kinney, President & CEO, Prothena Biosciences

BioTech Nation ... with Dr. Moira Gunn ·

2023/01/07

Prothena's 1-2-3 punch for Alzheimer’s + their work in Parkinson’s, ALS, and the role of Amyloids in Down Syndrome

en

48:54

22-52 Edward Humes, Pulitzer Prize Winner, "The...

BioTech Nation ... with Dr. Moira Gunn ·

2022/12/28

In a long-form feature from Tech Nation, it’s Pulitzer Prize-winning author, Edward Humes, with “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double Murder.” We get an object lesson in the Three Ages of DNA from a forensic investigation standpoint, and while it reads like a fast-paced Cold Case on steroids – it provides details no fiction writer would dare to make up, including the unexpected involvement of the famous true crimes writer, Ann Rule, and a person whose DNA

en

12:39

22-51 Keven Ali, CEO, Organon

BioTech Nation ... with Dr. Moira Gunn ·

2022/12/17

A new global company with 64 products, many of which are for women? Kevin Ali is the CEO of Organon.

en

13:47

22-50 Dr. Steve Worland, Co-Founder & CEO, eFFECTOR...

BioTech Nation ... with Dr. Moira Gunn ·

2022/12/14

Cancer is a hijacker, hijacking cells for its own purposes. And that’s where eFFECTOR Therapeutics is determined to intervene. Dr. Steve Worland, the Co-Founder & CEO, talks about just two of the candidates in its pipeline: One is for Non-small cell lung cancer and another for ER+ breast cancer, with these and other clinical trials enrolling now.

en

21:51

22-49 Dr. Zandy Forbes, Pres & CEO, MeiraGTx

BioTech Nation ... with Dr. Moira Gunn ·

2022/12/10

Like the idea of replacing some of your DNA with DNA that works better? And what if you want that new DNA to stop? Dr. Alexandria Forbes, the President & CEO of MeiraGTx, tells us about their work in retinitis pigmentosa and Parkinson’s – two of many clinical trials enrolling right now.

en

14:41

22-48 Dr. Robert Ang, President & CEO, Vor Biopharma

BioTech Nation ... with Dr. Moira Gunn ·

2022/12/07

Vor Biopharma has a unique approach to a particular kind of cancer – Acute Myeloid Leukemia – perhaps better known to you, as AML. Dr. Robert Ang is Vor's President & CEO.

en

16:40

22-47 Dr. James Mackay, President & CEO, Aristea...

BioTech Nation ... with Dr. Moira Gunn ·

2022/12/04

Too much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's called PPP, or Palmoplantar Pustulosis. Dr. James Mackay is the President & CEO of Aristea Therapeutics.

en

19:17

22-46 Dr. Maria Maccecchini, Founder, President &...

BioTech Nation ... with Dr. Moira Gunn ·

2022/11/30

Alzheimer’s, Parkinson’s and ALS, among others, are often grouped as Neurodegenerative Disorders. While they each present a different profile of symptoms, what do they have in common? Dr. Maria Maccecchini, the Founder, President & CEO of Annovis Bio, says, "Sticky proteins".

en

25:04

22-16 Triple-Negative Breast Cancer is the most...

BioTech Nation ... with Dr. Moira Gunn ·

2022/11/27

Anixa is pioneering a new approach to preventing the truly aggressive triple-negative form of breast cancer. Based on research from Cleveland Clinic, this approach has the potential to treat other breast cancers as well as ovarian cancer. Dr. Amit Kumar is the President & CEO. More information is available at anixa.com.

en

35:59

Dr. George Yancopoulos, CEO, Regeneron

BioTech Nation ... with Dr. Moira Gunn ·

2022/06/14

Dr. George Yancopoulosis is the President and Chief Scientific Officer of Regeneron. Regeneron is successful on many levels but is perhaps best known for its Covid treatment, directly infusing antibodies. This, of course, requires innovative science … but how do get students to become scientists? Dr. Yancopoulos has an answer.

en

13:52

Dr. Daniel Bloomfield, Chief Medical Officer, Anthos...

BioTech Nation ... with Dr. Moira Gunn ·

2022/06/13

Blood clots of any sort are dangerous. So dangerous in fact, that 1 in 4 people die from blood clots - independent of medical condition, medicines they take, or medical procedures they undergo. Dr. Daniel Bloomfield, the Chief Medical Officer of Anthos Therapeutics, describes their approach to preventing bleeding while avoiding blood clotting.

en

21:59

Mark Litton, President & CEO, Athira Pharma

BioTech Nation ... with Dr. Moira Gunn ·

2022/06/09

Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natural repair mechanisms in the brain. This, in turn, has generated new options for innovative treatments, and one such approach has entered late-stage human clinical trials. Dr. Mark Litton is the President and CEO of Athira Pharma.

en

155 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter